Not every prostate cancer patient wants to choose between surgery and surveillance. Transperineal Focal Laser Ablation offers a third path, and it requires far less specialized equipment than MRI-guided ablation does. That makes the procedure shorter, simpler, less costly, and considerably easier for patients to access. keep reading

For localized prostate cancer, the options can feel like two extremes: treat the whole gland and risk lasting side effects, or treat none of it and live with the worry of watching and waiting. Focal therapy sits in between. By destroying just the tumor and a small margin around it, it aims for cancer control close to radical treatment while preserving the quality of life that comes with treating none of the gland. keep reading

Why treat an entire prostate when the trouble usually starts in one spot? That question sits at the heart of focal therapy. For decades the answer was that doctors couldn't see or target the tumor precisely enough. Advances in multiparametric MRI, MRI-guided biopsy, and the index lesion concept finally changed that, opening a middle path between radical treatment and active surveillance. keep reading

Most men can name the usual prostate cancer risks: age, race, family history. A few others rarely make the list. Meat charred over high heat, how tall a boy grew during his teenage years, and even the kind of job a man works can each nudge his risk upward. None of them cause cancer outright, yet all three can tip the odds in ways worth understanding, and often in ways a man can act on. keep reading

Twenty-five years ago, most men diagnosed with localized prostate cancer were pointed toward one thing: surgery. Today the picture looks entirely different, with focal treatments and Active Surveillance firmly in the mainstream. The shift was not driven by fashion. It came from advanced imaging, more accurate biopsy, and long-term trial data that changed the calculus. keep reading

Ask how long you'll live and you get one number. Ask how many of those years you'll spend in good health and you get a very different one. The gap between the two is where planning matters most. Starting at 40, small shifts in exercise, diet, and screening can widen the healthy stretch and support prostate health along the way. keep reading

Most men over 45 grew up hearing that masturbation caused everything from blindness to acne. Harvard researchers found something closer to the opposite: men who ejaculated 21 times a month had a lower risk of prostate cancer than men who managed 4 to 7. A follow-up look at gene activity in prostate tissue hints at why that might be true. keep reading

Combining multiparametric MRI with genomic testing is revolutionizing prostate cancer detection and treatment. By leveraging the strengths of both technologies, doctors can achieve more accurate diagnoses, guide personalized treatment decisions, and improve patient outcomes. Learn how these tools are shaping the future of prostate cancer care. keep reading

Did you know over 95% of prostate cancers share the same name—adenocarcinoma? This common cell type is usually slow-growing, but not always. Understanding how it develops, why PSA levels matter, and what early detection can reveal is key to knowing your best treatment options. keep reading

Should every man on active surveillance be monitored the same way? New evidence suggests genetics may hold the answer. Polygenic risk scores could one day refine prostate cancer protocols, helping patients get care that matches their unique risk. keep reading